oxitadive stres,
Conditions
Interventions
20 mg/h infusion,
20mg intravenous bolus,
20 minutes locked time with tramadol,%0,
125 bupivacain,
4 ml/h infusion,
4 ml bl,
olu,
15 minutes locked time ,20 ml 0,
125 bupivacain
Active Comparator Drug,Active Comparator Drug,Active Comparator Drug
intravenous PCA,epidural PCA,sciatic and femoral bloc
Sponsors
none
Eligibility
Sex/Gender
All
Age
65 Years to 92 Years
Inclusion criteria
Inclusion criteria: proximal femur fracture, femoral nail operation, ASA I-III
Exclusion criteria
Exclusion criteria: need of postoperative intensive care admission, chronical analgesic use, norological imparement at lower extremities, coagulopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total thıol preoperative, peroperative, postoperative biochemical | — |
Secondary
| Measure | Time frame |
|---|---|
| disulphide preoperative, peroperative, postoperative biochemical | — |
Contacts
Public Contactcansu akın
fatih sultan mehmet
Outcome results
None listed